1. Kalra MK, Maher MM, Prasad SR, et al. Correlation of positron emission tomography and CT in evaluating pancreatic tumors: technical and clinical implications. AJR Am J Roentgenol 2003;181:387–393.
2. Moadel RM, Blaufox MD, Freeman LM. The role of positron emission tomography in gastrointestinal imaging. Gastroenterol Clin North Am 2002;31(3):841–861.
3. Iyer RB, Silverman PM, Tamm EP, Dunnington JS, DuBrow RA. Diagnosis, staging, and surveillance of pancreatic cancer. AJR Am J Roentgenol 2003;180:1311–1323.
4. Higashi T, Saga T, Nakamoto Y, et al. Relationship between retention index in dual-phase 18F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med 2002;43:173–180.
5. Valinas R, Barrier A, Montravers F, Houry S, Talbot JN, Huguier M. 18 F-fluorodeoxyglucose positron emission tomography for characterization and initial staging of pancreatic tumors. Gastroenterol Clin Biol 2002;26(10):888–892.